Chicago Partners Investment Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Buy
18,752
+2,548
+16% +$124K 0.02% 642
2026
Q1
$759K Buy
16,204
+442
+3% +$19K 0.02% 659
2025
Q4
$698K Buy
15,762
+6,795
+76% +$281K 0.02% 591
2025
Q3
$359K Buy
8,967
+1,670
+23% +$67.1K 0.01% 858
2025
Q2
$331K Buy
+7,297
New +$292K 0.01% 790
2025
Q1
– Sell
-7,156
Closed -$247K – 947
2024
Q4
$247K Buy
+7,156
New +$232K 0.01% 735
2018
Q4
– Sell
-3,245
Closed -$44K – 515
2018
Q3
$44K Buy
3,245
+1,200
+59% +$23.4K 0.01% 540
2018
Q2
$44K Buy
2,045
+945
+86% +$19.5K 0.01% 511
2018
Q1
$24K Hold
1,100
– – ﹤0.01% 585
2017
Q4
$33K Buy
+1,100
New +$29.3K 0.01% 522

Other funds holding EXEL

Chicago Partners Investment Group's EXEL Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Exelixis (EXEL) stake by 16% in Q2 2026, buying an estimated $124K and bringing the position to 18,752 shares worth $1.04M. The position accounts for 0.02% of the portfolio, ranked #642.

Chicago Partners Investment Group first reported a position in EXEL in Q4 2017 and has held it in 10 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Chicago Partners Investment Group held 18,752 shares of Exelixis worth $1.04M as of Q2 2026.
  • Chicago Partners Investment Group bought 2,548 Exelixis shares in Q2 2026, an estimated $124K.
  • Exelixis made up 0.02% of Chicago Partners Investment Group's portfolio in Q2 2026, its #642 holding.
  • Chicago Partners Investment Group first reported a position in Exelixis in Q4 2017 and has held it in 10 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.